Straits Times Index
3,343.35 +11.65 (+0.35%) S&P 500
5,484.96 +7.06 (+0.13%) Dow
39,233.72 +105.92 (+0.27%) Nasdaq
17,871.83 +66.67 (+0.37%) Bitcoin USD
61,762.69 +660.03 (+1.08%) CMC Crypto 200
1,288.99 +22.85 (+1.81%)
BDX Dec 2024 225.000 call
- PR Newswire
New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial launch of a new single-cell research tool to help scientists better understand how the molecular machinery within a cell functions and how it regulates changes in a cell that can lead to cancer and other diseases.
- PR Newswire
BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it plans to host webcasts to discuss quarterly financial results on the following dates:
- GuruFocus.com
Becton Dickinson & Co's Dividend Analysis
Becton Dickinson & Co (NYSE:BDX) recently announced a dividend of $0.95 per share, payable on 2024-06-28, with the ex-dividend date set for 2024-06-10. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Becton Dickinson & Co's dividend performance and assess its sustainability.
